Graduated from medical school of Zhejiang University in 1995, and acquired PhD and MD in General Surgery from Zhejiang University in 2005. In the year of 2012, studied in the Cancer Institute of New Jersey as a visiting scholar. Responsible for the perioperative management of the liver transplantation and the medical-care for post-transplantation patients from 2002. Also served as a senior clinical pharmacologist in clinical trials from 2006, including the safety, pharmacokinetics and tolerability study of new developing drugs, vaccines or novel cancer immunotherapy strategies such as CAR-T therapy, thus accumulated rich experience in clinical research of hepatobiliary and pancreatic cancer.